Bonus BioGroup Ltd.
BBIXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3 | $3 | $3 | $4 |
| G&A Expenses | $3 | $3 | -$6 | $3 |
| SG&A Expenses | $3 | $3 | -$6 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $8 | $0 |
| Operating Expenses | $6 | $6 | $6 | $7 |
| Operating Income | -$6 | -$6 | -$6 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$6 | -$6 | -$6 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$6 | -$6 | -$7 |
| % Margin | – | – | – | – |
| EPS | -0.009 | -0.009 | -0.008 | -0.006 |
| % Growth | 0% | -13.8% | -33.3% | – |
| EPS Diluted | -0.009 | -0.009 | -0.008 | -0.006 |
| Weighted Avg Shares Out | 699 | 699 | 699 | 1,168 |
| Weighted Avg Shares Out Dil | 699 | 699 | 699 | 1,168 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | -$0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$5 | -$5 | -$5 | -$6 |
| % Margin | – | – | – | – |